INIFY Laboratories AB (OSL:INIFY)
Norway · Delayed Price · Currency is NOK 3.980
+0.220 (5.85%)
At close: Feb 2, 2026
INIFY Laboratories AB Market Cap
INIFY Laboratories AB has a market cap or net worth of 323.21 million as of February 3, 2026. Its market cap has decreased by -11.11% in one year.
Market Cap
323.21M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
3.98
Market Cap Chart
Since June 20, 2022, INIFY Laboratories AB's market cap has decreased from 452.37M to 323.21M, a decrease of -28.55%. That is a compound annual growth rate of -8.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 2, 2026 | 323.21M | -15.37% |
| Dec 30, 2025 | 381.89M | 1.25% |
| Dec 30, 2024 | 377.20M | -32.76% |
| Dec 29, 2023 | 560.94M | 72.20% |
| Dec 30, 2022 | 325.75M | -27.99% |
| Jun 20, 2022 | 452.37M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 4.08B |
| Nordhealth AS | 2.95B |
| Photocure ASA | 1.84B |
| Thor Medical ASA | 1.72B |
| Lytix Biopharma AS | 711.84M |
| Navamedic ASA | 546.78M |
| Zelluna ASA | 393.99M |
| ContextVision AB | 296.01M |